Sign up to save your podcasts
Or
Share Ep 10: Oxford Nanopore: Creating Value through Local Partnerships
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Ep 10: Oxford Nanopore: Creating Value through Local Partnerships
Join me in ep 10 as I interviewed co-founder and CEO of Oxford Nanopore, Gordon Sanghera, and SVP of Population Health & Precision Medicine, Kathleen Barnes, during their visit to Singapore earlier this week.
(0:00) Introduction
(1:42) About Oxford Nanopore
(3:51) Applications in agriculture, food & environment
(5:11) Collaboration with Ministry of Health Singapore
(6:52) Collaboration with local ecosystem
(11:27) Challenges and opportunities in Southeast Asia
Oxford Nanopore was founded in 2005 as a spin-out from the University of Oxford. They developed the world’s first and only nanopore DNA and RNA sequencing platform — that offers scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data.
Dr Gordon Sanghera is co-founder and CEO of Oxford Nanopore. He has led the company through multiple finance rounds, and in 2021, a listing on the London Stock Exchange.
Kathleen Barnes is the SVP of Population Health & Precision Medicine at Oxford Nanopore. Kathleen’s career spans >30 years focused on genomic medicine and precision-driven health equity.
Subscribe now for more engaging discussions at the intersection of technology and healthcare. Stay curious, stay inspired, and delve into the world of #Medtech & #Biotech with us!
#precisionmedicine #precisionmedicine #deepmedtech #Medicalpodcast #Southeastasia #SEA #Medtechpodcast
View all episodes
By Natasha ZamanJoin me in ep 10 as I interviewed co-founder and CEO of Oxford Nanopore, Gordon Sanghera, and SVP of Population Health & Precision Medicine, Kathleen Barnes, during their visit to Singapore earlier this week.
(0:00) Introduction
(1:42) About Oxford Nanopore
(3:51) Applications in agriculture, food & environment
(5:11) Collaboration with Ministry of Health Singapore
(6:52) Collaboration with local ecosystem
(11:27) Challenges and opportunities in Southeast Asia
Oxford Nanopore was founded in 2005 as a spin-out from the University of Oxford. They developed the world’s first and only nanopore DNA and RNA sequencing platform — that offers scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data.
Dr Gordon Sanghera is co-founder and CEO of Oxford Nanopore. He has led the company through multiple finance rounds, and in 2021, a listing on the London Stock Exchange.
Kathleen Barnes is the SVP of Population Health & Precision Medicine at Oxford Nanopore. Kathleen’s career spans >30 years focused on genomic medicine and precision-driven health equity.
Subscribe now for more engaging discussions at the intersection of technology and healthcare. Stay curious, stay inspired, and delve into the world of #Medtech & #Biotech with us!
#precisionmedicine #precisionmedicine #deepmedtech #Medicalpodcast #Southeastasia #SEA #Medtechpodcast